ANNEXU.K.

Part A of Annex I to Regulation (EC) No 1334/2008 is amended as follows:

(1)

the entry concerning FL No 02.093 is replaced by the following:

‘02.093(Z)-Non-6-en-1-ol35854-86-532410294JECFA’
(2)

the entry concerning FL No 02.110 is replaced by the following:

‘02.1102,6-Dimethylhept-6-en-1-ol36806-46-9348At least 90 %; secondary component 5-10 % 2,6-dimethyl-5-hepten-1-olJECFA’
(3)

the entry concerning FL No 02.145 is replaced by the following:

‘02.1452,6-Dimethylocta-1,5,7-trien-3-ol29414-56-0EFSA’
(4)

the entry concerning FL No 02.194 is replaced by the following:

‘02.194Octa-1,5-dien-3-ol83861-74-9EFSA’
(5)

the entry concerning FL No 02.211 is replaced by the following:

‘02.211Undeca-1,5-dien-3-ol56722-23-7EFSA’
(6)

the entry concerning FL No 02.229 is replaced by the following:

‘02.229(-)-3,7-Dimethyl-6-octen-1-ol7540-51-4At least 90 % cis-isomer; secondary components 2-6 % di-unsaturated and saturated C10 alcohols, 2-4 % citronellyl acetate and 2-3 % citronellalEFSA’
(7)

the entry concerning FL No 02.252 is replaced by the following:

‘02.2524,8-Dimethyl-3,7-nonadien-2-ol67845-50-51841EFSA’
(8)

the entry concerning FL No 05.026 is replaced by the following:

‘05.026o-Tolualdehyde529-20-4EFSA’
(9)

the entry concerning FL No 05.028 is replaced by the following:

‘05.028m-Tolualdehyde620-23-5EFSA’
(10)

the entry concerning FL No 05.029 is replaced by the following:

‘05.029p-Tolualdehyde104-87-0EFSA’
(11)

the entry concerning FL No 05.085 is replaced by the following:

‘05.085(Z)-Hept-4-enal6728-31-03202124At least 93 % of Z-form of hept-4-enal; secondary component 2-5 % of E-form of hept-4-enal.JECFA’
(12)

the entry concerning FL No 05.137 is replaced by the following:

‘05.137Dec-4(cis)-enal21662-09-9At least 90 %; secondary component at least 5 % trans-isomerEFSA’
(13)

the entry concerning FL No 05.182 is replaced by the following:

‘05.1822,6,6-Trimethylcyclohex-2-ene-1-carboxaldehyde432-24-6EFSA’
(14)

the entry concerning FL No 07.190 is replaced by the following:

‘07.190Octa-1,5-dien-3-one65213-86-71848Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-formEFSA’
(15)

the entry concerning FL No 07.198 is replaced by the following:

‘07.198Pseudo-ionone141-10-611191EFSA’
(16)

the entry concerning FL No 07.202 is replaced by the following:

‘07.2022,6,6-Trimethylcyclohex-2-en-1-one20013-73-4EFSA’
(17)

the entry concerning FL No 07.204 is replaced by the following:

‘07.2043,3,6-Trimethylhepta-1,5-dien-4-one546-49-6EFSA’
(18)

the entry concerning FL No 07.255 is replaced by the following:

‘07.255l-Piperitone4573-50-61856EFSA’
(19)

the entry concerning FL No 08.004 is replaced by the following:

‘08.004Lactic acid50-21-59304EFSA’
(20)

the entry concerning FL No 09.016 is replaced by the following:

‘09.016Menthyl acetate16409-45-3431206JECFA’
(21)

the entry concerning FL No 09.131 is replaced by the following:

‘09.131DL-Isobornyl propionate2756-56-11391412EFSA’
(22)

the entry concerning FL No 09.132 is replaced by the following:

‘09.132Benzyl propionate122-63-4842413EFSA’
(23)

the entry concerning FL No 09.266 is replaced by the following:

‘09.266Hexyl 2-butenoate19089-92-0180710688EFSA’
(24)

the entry concerning FL No 09.562 is replaced by the following:

‘09.562trans-3-Hexenyl formate56922-80-6EFSA’
(25)

the entry concerning FL No 09.578 is replaced by the following:

‘09.578Hexyl (E)-but-2-enoate1617-25-010688EFSA’
(26)

the entry concerning FL No 09.596 is replaced by the following:

‘09.596Isopentyl-(Z)-but-2-enoate10482-55-0EFSA’
(27)

the entry concerning FL No 09.854 is replaced by the following:

‘09.854cis-3-Hexenyl 2-methylbutanoate53398-85-9EFSA’
(28)

the entry concerning FL No 09.858 is replaced by the following:

‘09.858Phenylmethyl 2-methyl-2-butenoate67674-41-3Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-formEFSA’
(29)

the entry concerning FL No 09.880 is replaced by the following:

‘09.880(Z)-Hept-4-en-2-yl butanoate94088-12-7EFSA’
(30)

the entry concerning FL No 09.936 is replaced by the following:

‘09.9364,8-Dimethyl-3,7-nonadien-2-yl acetate91418-25-61847EFSA’
(31)

the entry concerning FL No 12.075 is replaced by the following:

‘12.075Methyl prop-1-enyl disulfide5905-47-556911712At least 90 %; secondary components 3-4 % dimethyl disulfide and 3-4 % di-1-propenyl disulfideJECFA’
(32)

the entry concerning FL No 12.086 is replaced by the following:

‘12.086S-Methyl 2-methylbutanethioate42075-45-6486JECFA’
(33)

the entry concerning FL No 12.273 is replaced by the following:

‘12.2733-(Methylthio)heptanal51755-70-51692At least 92 %; secondary component 5-7 % (E)-hept-2-enalEFSA’
(34)

the entry concerning FL No 13.028 is replaced by the following:

‘13.0282-Butyl-5 or 6-keto-1,4-dioxane65504-95-214842206EFSA’
(35)

the entry concerning FL No 13.170 is replaced by the following:

‘13.1702S-cis-Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran3033-23-6EFSA’
(36)

the entry concerning FL No 13.190 is replaced by the following:

‘13.1903-((2-methyl-3-furyl)thio)-2-butanone61295-44-11525EFSA’
(37)

the entry concerning FL No 14.067 is replaced by the following:

‘14.0672-Ethoxy-3-methylpyrazine32737-14-779311921At least 82 % 2-ethoxy-3-methylpyrazine. Secondary components 15 % 2–ethoxy-5-methylpyrazine (CAS no 67845-34-5) or 2-ethoxy-6-methylpyrazine (CAS no 53163-97-6)EFSA’
(38)

the entry concerning FL No 15.134 is replaced by the following:

‘15.1342,5-Dihydroxy-1,4-dithiane40018-26-6550Mixture of diastereoisomers: 25-30 % of (2S,5S and 2R,5R) and 70-75 % (2S,5R and 2R,5S)EFSA’
(39)

the entry concerning FL No 16.095 is replaced by the following:

‘16.095Cyclopropanecarboxamide, N-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-744251-93-21779EFSA’
(40)

the entry concerning FL No 16.123 is replaced by the following:

‘16.123(1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide68489-09-8EFSA’
(41)

the entry concerning FL No 17.015 is replaced by the following:

‘17.015DL-Methylmethioninesulphonium chloride3493-12-71427761EFSA’